Join our community of smart investors

Ailsa Craig: “pharma used to have a worse reputation than tobacco”

Ailsa Craig of International Biotech Trust discusses the outlook for the global biotech industry in the post pandemic world
Ailsa Craig: “pharma used to have a worse reputation than tobacco”

We’re all very grateful to the healthcare industry for the amazing work it has done to create vaccines and treatments to help fight the pandemic. But what is the investment outlook now for the companies in the biotech sector?

In this interview, Ailsa Craig of the International Biotechnology Trust (IBT) shares what types of companies she looks to own, where she sees the value in the biotech industry currently and how the development of coronavirus treatments has impacted holdings in the fund. 

To continue reading...
REGISTER FOR FREE TODAY
  • Read 3 articles for free each month
  • Educational articles and topical investment guides
  • In-depth podcast episodes by our writers and industry professionals
  • Interactive live webinars on investment themes that matter
Have an account? Sign in